S02057, the “Beauty Justice Act,” would amend the Environmental Conservation Law to regulate ingredients in personal care products and cosmetics sold in New York. The bill creates a new title in Article 37 defining “personal care product,” “cosmetic product,” “manufacturer,” and a long list of “restricted substances,” including certain heavy metals, phthalates, PFAS, formaldehyde and formaldehyde releasers, triclosan, asbestos, benzene, toluene, and several other chemicals and dyes. It also directs the Department of Environmental Conservation to identify safer alternative chemicals and to adopt implementing regulations, while requiring the department to consider research, other states’ laws, and input from cosmetologists, small businesses, and small manufacturers.
The bill would prohibit, beginning January 1, 2029, the sale or offer for sale in New York of personal care or cosmetic products containing any restricted substance as an intentionally added ingredient, and would set a separate lead limit to be established by regulation at the lowest feasible level, with periodic review every five years. It also gives the department authority to identify and phase in restrictions on certain formaldehyde-releasing chemicals through rulemaking. Sellers could avoid liability if they relied in good faith on a manufacturer’s certificate of compliance, but manufacturers could be penalized for issuing false certificates. Civil penalties would be added to the Environmental Conservation Law for violations, and the act would take effect one year after becoming law.
The bill’s impact on state law is significant because it creates a new statewide product-safety regime for cosmetics and personal care items, expanding New York’s authority over chemical ingredients in consumer products. It would add new regulatory duties for the Department of Environmental Conservation, create compliance obligations for manufacturers and retailers, and establish enforcement tools including daily civil penalties and injunctive relief. The measure is also framed as filling a gap left by federal law, while explicitly relying on state authority to impose stricter restrictions than current federal standards.
Overall sentiment around the bill appears favorable. It was reported favorably from the Senate Environmental Conservation Committee and passed the Senate floor with clear majorities in the recorded votes, suggesting broad support for the bill’s public-health and consumer-protection goals. The findings section emphasizes health risks, disproportionate exposure concerns, and the need to protect consumers and salon workers, which aligns with the supportive vote totals.
The main points of contention are likely to center on the breadth of the chemical restrictions, the compliance burden on manufacturers and retailers, and the potential effects on small businesses and salon operators. The bill anticipates these concerns by directing the department to consider stakeholder input from independent cosmetologists, small businesses, and small manufacturers, and by allowing reliance on manufacturer compliance certificates. Another likely issue is the use of a long, detailed restricted-substance list and the department’s discretion to phase in formaldehyde-related restrictions through regulation.
This bill would add a new Title XII to Article 37 of the Environmental Conservation Law, creating a comprehensive state-level restriction on certain chemicals in cosmetics and personal care products. It would prohibit the sale of products containing listed restricted substances, establish a lead threshold to be set by regulation, require identification of safer alternatives, and authorize civil penalties and injunctions for violations. Manufacturers, distributors, and retailers of cosmetics and personal care products would be directly affected, along with the Department of Environmental Conservation, which would gain new rulemaking and enforcement responsibilities.
The available voting history indicates strong support for the bill. It advanced out of the Senate Environmental Conservation Committee by a 10-1 vote and passed the Senate floor by substantial margins in both recorded votes. The bill’s findings and structure reflect a public-health-oriented approach, and the lack of recorded opposition in the provided materials suggests that concerns did not prevent broad legislative approval, though some members likely remained wary of regulatory and business impacts.
The likely areas of contention are the scope of the chemical bans, the feasibility of compliance, and the effect on small businesses and product manufacturers. Retailers and manufacturers may be concerned about the breadth of the restricted-substance list, the lead standard to be set at the lowest feasible level, and the need to reformulate products or obtain compliance certifications. The bill itself acknowledges these concerns by requiring the department to consider input from independent cosmetologists, beauty salons, and small manufacturers, and by creating a good-faith reliance defense for sellers who receive manufacturer certifications.